Spina E

References (4)

Title : A case of severe increase of liver enzymes in a ATTRv patient after one year of inotersen treatment - Severi_2022_Neurol.Sci__1
Author(s) : Severi D , Palumbo G , Spina E , Iovino A , Nolano M , Manganelli F , Tozza S
Ref : Neurol Sci , :1 , 2022
Abstract :
PubMedSearch : Severi_2022_Neurol.Sci__1
PubMedID: 36576645

Title : Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? - Trifiro_2009_Pharmacol.Res_59_1
Author(s) : Trifiro G , Spina E , Gambassi G
Ref : Pharmacol Res , 59 :1 , 2009
Abstract :
PubMedSearch : Trifiro_2009_Pharmacol.Res_59_1
PubMedID: 18977443

Title : Clinically significant pharmacokinetic drug interactions with carbamazepine. An update - Spina_1996_Clin.Pharmacokinet_31_198
Author(s) : Spina E , Pisani F , Perucca E
Ref : Clinical Pharmacokinetics , 31 :198 , 1996
Abstract :
PubMedSearch : Spina_1996_Clin.Pharmacokinet_31_198
PubMedID: 8877250

Title : Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects - Pisani_1992_Br.J.Clin.Pharmacol_34_85
Author(s) : Pisani F , Fazio A , Artesi C , Oteri G , Spina E , Tomson T , Perucca E
Ref : British Journal of Clinical Pharmacology , 34 :85 , 1992
Abstract :
PubMedSearch : Pisani_1992_Br.J.Clin.Pharmacol_34_85
PubMedID: 1352988